SAN FRANCISCO – Feeling unloved by Wall Street, undercompensated by payers and abandoned by big pharma, members of the Antimicrobials Working Group (AWG) and other key stakeholders gathered Friday morning at IDWeek to chart a path out of dire market circumstances.